Lucence Revenue and Competitors
Estimated Revenue & Valuation
- Lucence's estimated annual revenue is currently $15.8M per year.
- Lucence's estimated revenue per employee is $155,000
Employee Data
- Lucence has 102 Employees.
- Lucence grew their employee count by 7% last year.
Lucence's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP, US Operations | Reveal Email/Phone |
2 | Clinical Laboratory Scientist III - General supervisor | Reveal Email/Phone |
3 | Medical Technologist | Reveal Email/Phone |
Lucence Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Lucence?
Lucence is an oncologist-founded precision oncology company with the vision of a world without avoidable cancer deaths. The company pioneers ultrasensitive liquid biopsy tests and state-of-the-art data analytics for early cancer detection and treatment selection. Visit www.lucence.com for more information.
keywords:N/A
N/A
Total Funding
102
Number of Employees
$15.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lucence News
2022-03-30 - Liquid Biopsy Market 2022 Top Leading Players, Recent Developments,
Opportunities, Size, Revenue, Sales, Regional Analysis, Business
Strategies, Challenges, Types, Applications
In November 2019, Lucence Diagnostics Pte Ltd, a genomic medicine company based in Singapore, raised US$ 20 Million in Series A funding. In June...
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $33.2M | 102 | N/A | N/A |
#2 | $14.8M | 102 | 31% | $1.3M |
#3 | $14.3M | 102 | -14% | $61.4M |
#4 | $13.4M | 103 | -38% | $85.3M |
#5 | $3.5M | 103 | -3% | N/A |